Pur pose. Recently we showed that the 68-kDa fusion protein derived from the EW S/FLI1 hybrid gene can be speci® cally detected by Western blotting using a polyclonal antibody to the C -terminal of FLI1 on biopsy material from Ewing's sarcoma. The aim of this study was to investigate whether this antibody also could be used for immunocytochem istry and immunohistochemistry in diagnosis of Ewing's sarcoma. M eth ods. Imm unostaining on paraffin-embedded archival material, ® ne-needle aspirates and tumour touch imprints from Ewing's sarcomas and primitive neuroectodermal tumours (PN ET) for detection of the fusion protein was perform ed. M ost cases were also analysed by Western blotting. Tumours of differential diagnostic importance were also included. Results. Eighty per cent (12/15 cases) of the Ewing tumours exhibited a positive immunoreactivity for the FLI1 antibody. The signal was m ainly localised in the nuclei of the tumour cells, which seems reasonable since E W S/FLI1 is a transcription factor. The signal was found to be speci® c since it did not appear when the blocking peptide was added to the antibody solution. M oreover, two other types of small-round cell tumours (i.e. neuroblastoma and alveolar rhabdomyosarcoma) were negative as well as m ost normal tissues. Discussion. Imm unostaining of histological and cytological specimens with the FLI1 antibody can be of diagnostic relevance in Ewing tumours carrying t(11;22). The absence of imm unoreactivity in non-Ewing cells is m ost likely due to a low expression of the wild-type FLI1 protein.
Introduction
M orphological diagnosis of Ewing's sarcom a and prim itive neuroectoderm al tum ours (PN ET), based on biopsies or ® ne-needle aspirates, is often asso ciated with severe difficulties. 1± 3 Ewing tumours (ET s)
are recognised as tum our tissue com posed of sm all round cells, and can be m isdiagnosed as other sm allcell tumours like lymphom a, neuroblastoma and rhabd om yo sa rco m a, o r eve n ben ign co n d itio n s lik e osteomyelitis. 4± 7 ET s are seen m ainly in childhood and in this age group it accounts for approxim ately one fourth of all m alignancies, or 29 per m illion children. 5 Since ET is very prim itive, no structural, enzym atic or cell surface characteristics speci® c for this entity exist. Diagnosis is therefore frequently m ade by excluding other differential diagnostic possib ilities. 6 O ver the last years several ET-spe ci® c translocations have been discovered. N inety per cent of the ET cases carries the translocation t(11;22)(q24;q12), 5% t(21;22)(q22;q12) and <1% t(7;22)(p22;q12). 8± 12 Recently, two additional chromosomal translocations in Ewing's sarcom a have been described, t(17;22) and t(2;2 2). 13, 14 Analysis of translocations by reverse transcriptionÐ polym erase chain reaction (RT-PCR) is a useful option in the diagnosis of ET. 15 A limitation, however, with RT-PCR in surgical pathology is the requirement for a strict and rapid handling of fresh material to avoid degradation of tumour cell m RNA. The possibility of simply analysing the product of the EW S/FLI1 fusion gene [i.e. t (11;22) ] on a processed surgical specimen would therefore provide an important diagn ostic tool, especially if suitable m aterial for RT-PCR is not available. Recently, we applied Western blotting, using an antibody against the carboxy terminal of the FLI1 protein (sc-356 or C-19), for detection of the 68-kD a EW S/FLI1 fu sion protein in surgical biopsies of Ewing's sarcom a. We could con® rm that this antibody is highly speci® c since the fusion protein was only detected in Ewing's sarcom a cells carrying t(11;22)(q24;q12). 16 The lowest detection level for total protein was 0.3 m g.
Antibodies against the M IC2 gene product are com m only used in diagnosis of Ewing's sarcom a. 17, 18 However, several other tumours (including lym phom a and rhab domyosarcom a) have been reported to be im m unoreactive to M IC -2 antibodies. 18, 19 In the present study we have investigated whether the FLI1 antibody can be used for detection of EW S/FLI1 using im m unocytochem istry and im m unohistochem istr y. Such an application would be very useful in diagnosis of ET on cytological and paraffin-e m bedded samples. 
M ethods

Chem icals
Cell lines
T he E wing's sarcom a cell line HT B-166 carr ying the t( 
Tum our m aterial
Fresh-frozen surgical biopsies from clinical cases were used for Western blotting and/or im m unocytochemistry. Two ® ne-needle aspirates and nine tum our touch im prints were put on Superfrost slid es (M enzelGlaser, G erm any) and air-dried for im m unostaining. Sections for im m unostainings were obtained from form alin-® xed paraffin-em bedded archival m aterial.
Im munohistochem istry and im munocytochem istr y
Im m unostaining was perform ed using the standard ABC -techn iqu e (Vector, E lite Stan dard K it. cat. PK-6100). Paraffin sections were deparaffinised, rehydrated and subjected to m icrowaves (700 W ) for 5 m in . T he en d ogenou s peroxidase activity of the pre-treated sections and cytological slides was blocked by hydrogen peroxide (H 2 O 2 ) dissolved in m ethanol (3% H 2 O 2 : m ethanol, 1:5 by volum e) for 30 m in. Sections and slides were then rinsed and incubated with blocking serum (norm al horse serum ) for 20 m in. E xcess serum was drained and the slides were incubated with the Sc-356 (C-19) antibody at a 1:200 dilution or C D 99 at 1:3 00 dilution. Sc-356 w as incubated overnight at +8Ê C and CD99 was incubated for 1 h at room tem perature. A biotinylated antirabbit IgG was used as a secondary antibody and followed by the ABC -com plex. T he peroxidase reaction was developed using DAB (Diam inobenzidine tetrahydrochloride, 0.6 m g/m l with 0.03% H 2 O 2 ) for 6 m in . C o u n ter stain in g w as p erfo r m e d . Tr isphosph ate buffered saline (pH 7.6) was used for rinsing between the different steps.
Protein isolation
Total protein was isolated as described elsewhere. at 6003 g at 4Ê C the pellet, containing unbroken cells and cytoskeleton, was discarded. The supernatant was used for analysis. The concentration of total protein was m easured using the Bio-Rad protein assay (BioRad, Germany) according to the method of Bradford.
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G el electrophoresis
Proteins were dissolved in a sam ple buffer containing 0.0625 M Tris± H C l (pH 6.8), 20% glycerol, 2% sodium dodecyl sulphate (SD S), brom ophenol blue and 100-m M dithiothreitol. Sam ples o f variable pro tein con centration s w ere analyse d by sodium dodecyl sulphate± polyacrylam ide gel electrophoresis (SD S± PAGE ) w ith a 4% stacking gel and a 10% s ep a ra tio n ge l at 1 0 0 V o ver n ig h t, e sse n tia lly according to the protocol of L aem m li. 24 T he 53 r unn ing bu ffer w as pre pared by m ixing 15 g Tris base, 72 g glycin e and 5 g SD S in 1 l distilled water, p H 8.3. A 20 m l SeeB lu e Pre-S tain ed S tand ard (N OV EX , San D iego, U SA ) was ru n sim u ltaneou sly. T hree gel-elecrophore ses were ru n for each m aterial, on e of w hich w as stain ed w ith C oom assie blu e to m o nitor the quality of the protein s. T he two other gels were use d for Western blo ttin g.
Wester n blotting
A ft er S D S ± PAG E th e sep arated p ro tein s w e re transferred at 100 V for 3 h to a H ybond-E CL nitro- 
Results
Fresh-frozen biopsy m aterial from a typical case of ET was used in the ® rst experim ent. Separate sam ples were used for Western blotting and for im m unostaining of ® ne-needle aspirates.Western blotting using th e F L I1 a n tib o d y sh o w ed a 6 8-k D a p ro d u ct cor re sp on d in g to th e E W S /F L I1 fu sio n protein (Fig. 1a) . As a control, a sam ple from norm al ® broblasts was also analysed. T his sam ple was found to be negative (Fig 1a) . It was con® rm ed in a separate experim ent that the 68-kD a band did not appear if the control peptide (sc-356P) was added to the antibody solution (data not shown). Figure 1(b) shows im m unostaining w ith sc-3 56 (C -1 9) of the ® n eneedle aspirate of the sam e case. T here was a clear positive im m unoreactivity of the cells, and this was m ainly con® ned to the cell nuclei. In Fig. 1(c) the sc-356 im m unoreactivity in a ® ne-needle aspirate of another typical ET case is shown. In Fig. 2 it is dem onstrated that a form alin-® xed
. (a) Detection by Wester n blotting of the 68-kDa E W S/FL I1 fusion protein in a ET sam ple using the FLI1 antibody sc-356 (C -19). (b) Imm unosta ining with the FLI1 antibody on a ® ne-need le aspirate m aterial from the aforem entioned E T sam ple. (c) Imm unostaining with the FLI1 antibody on cytolog ical sam ple from another E T case . (3 400)
and paraffin-embedded archival specimen of E T was positively stained by sc-356 (C -19). Even in this case the im m unoreactivity was m ainly con® ned to the nuclei. In order to get this positive signal, antigen retrieval using m icrowave treatment was necessar y (see M aterials and M ethods). As can be seen in the right panel of Fig. 2 , the im m unoreactivity was totally lost if the control peptide (sc-356P) was add ed together with the primary antibody during the staining procedure. In a separate experim ent we could confirm that sc-356P did not decrease the im m unoreactivity Figure 3 show s the result from Western blotting using the sc-356 (C-19) antibody on various types of ET and non-E T cells and tissues. T he purpose of this experim ent was to investigate if there was any detectable wild-type F LI1 in the cells. A positive im m unostain in g fo r F L I1 in th e n o n -E T cells w o u ld considerably decrease the utility of im munostaining in distinguishing between E T and non-ET cells. As demonstrated all sam ples analysed, including ET cells w ith the t(21;22) translocation and neuroblastom a tissue, showed no positive signals for FLI1, which has a m olecular weight of 51 kD a. In Fig. 4 (a± d) im m unochem istry of four different cases of ET (with known t(11;22) translocations), and in Fig. 4 (e± f) im m unohistochem istry of two cases of sm all-round cell non-ET tum ours (i.e. neuroblastoma and alveolar rhab domyosarcom a), are shown. All ET cases were positively stained, w hereas the non-E T cases showed no signi® cant im m unoreactivity. Two additional cases of rhabdomyosarcom a and neuroblastoma were found to be negative for the FLI1 antibody (data not show n). Two cases of nonHodgkin's lymphom a were also negatively stained
of irrelevan t an tibo d ies (lik e M IC -2 ) (d ata n o t show n). Taken together, these results strongly suggest that sc-356 (C-19) does not cross-reac t with other proteins in the cells.
F ig. 2. Imm unohistoch em istr y using the FLI1 antib ody sc-356 (C-19) on a paraffin-em bedded ET specim en (left panel). Speci® city on the FLI1 antibody was tested using the peptide against which the FLI1 antibody was raised (right panel
(a) (b) (c) (d) (e) (f) F ig. 4
. Imm unoh istochem istr y using the FLI1 antibody on four different paraffin-em bedded E T specim en (a± d), as well as on a neuroblastom a (e), and an alveolar rhabdomyosarcom a (f). (3 400)
( Table 2 below ) . H oweve r, Wester n blottin g an alysis of two other lym phom a cases (ou t of fou r analysed cases) showed positive sig nals for w ild-type F L I1 (Table 2) . To fur ther evaluate the FLI1 antibody we prepared tum our touch im prints from nine other fresh frozen ET biopsies. Im m unostaining was perform ed w ith sc-356 (C -19) and C D -99 (M IC -2). The results are presented in Table 1 . Parallel biopsy sam ples were analysed for 68-kD a fusion protein using Western blotting. U nfortunately, the quality of these sam ples was not good enou gh for RT-PC R due to RN A degradation. H owever, the isolated protein s were con® rm ed to be intact as assaye d by SD S± PAGE and Coom assie Blue staining.Therefore we could compare the im munostainings with Western blotting data. Eight cases showed a positive 68-kD a signal for the fusion protein in the Western blotting analyses, ® ve of w hich were also positive in the im m unostainings. Two other im m unoim prints could not be evaluated by technical reasons. T he case being negative in Western blotting (case 6) was also negative for C-19 in the im m unoimprints (Table 1) . T his case was, however, positive for M IC -2. T he im m unonegativity of case 6 could be du e to an alter n ative translo cation , e.g. t(2;2 2), t(7;22), t(17;22) or t (21;22) . In only one of the cases there was a discrepancy between Western blotting and imm unostaining (case 2) ( Table 1) . This m ight be explained by that the EW S/FLI-1 expression was too low to be detected by im m unocytochemistry. We also tested the im m unoreactivity in different types of norm al hum an tissues, including bone, m uscle and skin. Apart from an interm ediate im m unoreactivity in endothelial cells of som e vessels, all other tissues investigated were negative (Table 2 ). In som e cases in¯am m atory cells adjacent to in® ltrates to E wing tum our tissue showed a slightly positive im m unostaining (Table 1) . H owever, in four cases of §Some vessels showed positive staining in the endothelial cells.
osteomyelitis the in¯am m ator y cells were negatively stained (Table 2) .
D iscussion
T he m olecular analysis of the t(11;22) rearrangem ents is likely to be of diagnostic value in Ewing's sarcom a and PN ET. 25 M oreover, m olecular analysis of tum our-assoc iated gene rearrangements com prises an im portant tool in disclosing mechanism s of oncogen esis. It se em s clear that the fo r m ation o f a transcription factor from the EW S/FLI1 hybr id gene is a n ecessar y step in tu m o u r igen esis o f E T. 26 Recently, we showed that the 68-kD a EW S/FLI1 fusion protein can be detected by Western blotting using an antibody (C-19) against the carboxy term inal of the FL I1 protein. 16 T he aim of this study was to investigate whether im m unostaining with C -19 could be used in diagnosis of ET. Using another FLI1-sp eci® c antibody, M elot et al. could detect the EW S/FLI1 fusion protein by im m uno¯uorescense on cell lines. 27 As shown in the present study, positive im m unostaining of ET was found in both cytological sam ples and form alin-fixed paraffin-em bedded surgical specim ens. The im m unoreactivity was m ainly localised in the nuclei of the tu m o u r cells, w hich seem s reaso nable sin ce the E W S/F L I1 p rotein fu n ctio n s as a tran scr ip tio n factor. 28 It was con® rm ed that the im m unoreactivity was not due to cross-re activity to other proteins. In order to perform speci® c diagnosis of ET using im munostaining w ith C -19 it is of great im portance that the wild-type FLI1 protein is not, or only slightly, expressed in norm al tissue and in tumours that pose differential diagnostic problem , like neuroblastom a an d rhabdo myo sarcom a. In this study we cou ld con® rm that C -19 im m unostainings of neuroblasto m a a n d rh a bd o m yo sarc o m a s w ere n eg ative. F urtherm ore, m ost norm al tissues, w ith the exception of endothelial cells and in¯am m atory cells, were not im m unoreactive. We also tested various types of non-ET cells and ET cells (including ET carrying t(21;22)) for the wild-type FLI1 protein using Western blotting. All of these were also found to be negative. In co n tra st , Wester n b lo ttin g a n a ly sis o f so m e ly m p h o m a tissu es sh ow ed a p o sitive sign al corresponding to w ild type FLI1. T his result is not surprising since it is known that heam atopoetic cells can express FLI1. 29 Therefore, despite negative im munoreactivity in two lym phom a and four osteomyelitis cases, we believe that im m unostaining with C-19 is not fully reliable to distinguish ET from lym phom a. H owever, the parallel use of alternative m arkers, like leukocyte com m on antigen (LCA), in these cases could be helpful in this m atter. Taken together, our present results suggest that im m unostaining with FLI1 antibodies can be valuable in the diagnosis of Ewing's sarcom a and PN E T, both on cytological m aterial and surgical biopsies.
